Anastasia Nikiforov Email

Scientist|Immuno-Oncology . Corner Therapeutics

Current Roles

Employees:
38
Revenue:
$5.9M
About
Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.
Corner Therapeutics Address

Watertown, MA
United States
Corner Therapeutics Email

Past Companies

Corner TherapeuticsScientist|Immuno-Oncology
Scholar RockProtein Expression|Cell Line Engineering Scientist
Claritas GenomicsScientist II- Research and Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.